Actinogen Medical Ltd: ACW presents at Sachs Neuro & WHO grants INN emestedastat
Actinogen Medical Ltd: Change in substantial holding
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: ACW to list $0.05 options exp 31 May 2027 - ASX code ACWOD
Actinogen Medical Ltd: Listed Options Top 20 & Distribution Schedule
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: ACW randomizes first US participant in Alzheimers trial
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Notification of cessation of securities - ACW
Actinogen Medical Ltd: Notification of cessation of securities - ACW
Actinogen Medical Ltd: Results of Annual General Meeting
Actinogen Medical Ltd: Actinogen 2024 AGM, Chairs address and CEOs presentation
Actinogen Medical Ltd: Actinogen receives $9.0 million R&D tax incentive rebate
Actinogen Medical Ltd: Notification of buy-back - ACW
Actinogen Medical Ltd: Appendix 3Ys x 4
Actinogen Medical Ltd: Cleansing Notice
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Application for quotation of securities - ACW
Actinogen Medical Ltd: Results of General Meeting
Actinogen Medical Ltd: ACW CMO presents academic poster at CTAD 2024 conference
No Data